Publication | Closed Access

Receptor tyrosine kinase inhibitors block proliferation of TGEV mainly through p38 mitogen-activated protein kinase pathways

Signal TransductionMedicineReceptor Tyrosine KinaseImmunologyAntiviral Drug DevelopmentAntiviral ResponseAdult T-cell Leukemia-lymphomaImmunotherapyPharmacologyCell BiologyCell Signaling